University Of Washington

Hospitals in the United States implemented new policies based on the severe 2017-2018 influenza season, but experts agree that America’s health care systems would still be seriously challenged by another bad season.

Blinatumomab appeared to confer better outcomes than standard of care among adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia, according to results of a propensity score analysis published in Cancer.

Incidence of invasive melanoma decreased among adolescents and young adults in the United States between 2006 and 2015, according to results of a population-based study published in JAMA Dermatology.

NATIONAL HARBOR, Md. — Allogeneic activated natural killer cell therapy resulted in some antitumor activity with no serious side effects in patients with metastatic Merkel cell carcinoma, according to the results of a phase 2 study presented at the SITC Annual Meeting.

The National Academy of Medicine announced the election of 90 regular members and 10 international members.

Oncologists, and physicians in general, are trained to strive for excellence, remain strong and resilient in the most difficult circumstances, and devote themselves to the patients who depend on them.

Imagine a young adult male in his late 20s picks up his cell phone and calls his mother. Overtly emotional and on the verge of releasing a full-out flow of tears, the young man says to the voice at the other end of the line, “Mom, there’s hope.”

Cameron Turtle, MD, PhD, a pioneer in the field of chimeric antigen receptor T-cell therapy, has been honored as the inaugural recipient of the Anderson Family Endowed Chair for Immunotherapy at Fred Hutchinson Cancer Research Center.

A dramatic increase in the rate of Merkel cell carcinoma has attracted new attention to this rare and aggressive skin cancer.

The Seattle Cancer Care Alliance, the clinical care partner of the Fred Hutchinson Cancer Research Center, has been at the forefront of cellular therapies for cancer treatment since the field emerged. It was there where E. Donnall Thomas, MD, and his team pioneered the use of bone marrow transplant during the 1970s and SCCA’s position remains unchanged in the field of cellular therapies as its research and clinical staff have administered more CAR T-cell therapies to patients than any other facility in the world.